PKM and urinary bladder carcinoma: As PKM2 dimer and tetramer have fundamentally different enzymatic activities, we suggested the mechanisms of Shikonin in bladder cancer cells may not only act through reductions in glycolysis, but also through alterations in anabolic cancer metabolism that allows for cell growth via synthesis of other necessary intermediates.